
Panitra I 40mg/150mg Capsule SR
Marketer
Astrica Biomedics Pvt Ltd
Salt Composition
Pantoprazole (40mg) + Itopride (150mg)
Overview Panitra I 40mg/150mg Capsule SR
Gastroesophageal reflux disease (GERD) and functional dyspepsia are effectively managed with Panitra I 40mg/150mg sustained-release capsules. This medication alleviates common acidity symptoms, including heartburn, stomach upset, and irritation, by neutralizing stomach acid and facilitating gas expulsion. Panitra I should be taken on an empty stomach, following your physician's prescribed dosage and regimen. Treatment duration depends on individual response and condition severity; premature discontinuation may lead to symptom recurrence and condition exacerbation. Complete disclosure of all other medications to your healthcare provider is crucial, as interactions are possible. While diarrhea, abdominal pain, headache, flatulence, and increased salivation are common, mostly transient side effects, prompt medical attention is advised for any concerning symptoms. Drowsiness and dizziness are potential side effects; avoid driving or mentally demanding tasks until the medication's impact is known. Alcohol consumption should be avoided due to potential additive drowsiness. Dietary changes, such as consuming cool milk and avoiding caffeinated beverages, spicy foods, and chocolate, can enhance treatment outcomes. Prior to commencing treatment, inform your doctor of any kidney conditions, pregnancy, pregnancy planning, or breastfeeding.
Primary Ingredients of Panitra I 40mg/150mg Capsule SR
No text provided. Please provide the text you wish me to rephrase.
Uses of Panitra I 40mg/150mg Capsule SR
Stomach acid regurgitation (GERD)
Major Benefits of Panitra I 40mg/150mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Panitra I 40mg/150mg SR capsule should be swallowed whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Panitra I 40mg/150mg Capsule SR:
- Diarrhea
- Stomach pain
- Headache
- Flatulence
- Dizziness
- Increased saliva production
- Dryness in mouth
How to use Panitra I 40mg/150mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Panitra I 40mg/150mg SR Capsules. Ingest the capsules whole; avoid crushing, chewing, or breaking them. Administer on an empty stomach.
How Panitra I 40mg/150mg Capsule SR works:
Panitra I 40mg/150mg sustained-release capsules contain pantoprazole and itopride, working synergistically to manage acid-related digestive issues. Pantoprazole, a proton pump inhibitor (PPI), lessens stomach acid production, alleviating indigestion and heartburn. Itopride, a prokinetic agent, influences the brain's vomiting center and enhances gastrointestinal motility, facilitating smoother food passage through the upper digestive tract.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Panitra I 40mg/150mg SR capsules with alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
Data on Panitra I 40mg/150mg sustained-release capsules and pregnancy are currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Panitra I 40mg/150mg sustained-release capsules while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Panitra I 40mg/150mg sustained-release capsules could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data on Panitra I 40mg/150mg sustained-release capsules in patients with renal impairment is scarce. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Use of Panitra I 40mg/150mg SR capsules in patients with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Panitra I 40mg/150mg Capsule SR :
Should you forget to take a Panitra I 40mg/150mg sustained-release capsule, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Panitra I 40mg/150mg Capsule SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Medication Category | Gastrointestinal system |
